Prothena Corporation plc
Overview
Prothena Corporation plc is a biotech company headquartered in Ireland that specializes in discovering and developing novel therapies for neurodegenerative and rare peripheral amyloid diseases. The company's innovative pipeline focuses on protein dysregulation as a key biological pathway for drug development.
Therapeutic areas
Neurodegenerative diseasesRare peripheral amyloid diseases
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Prothena Corporation plc in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.